Point72 Asset Management
IBB icon

Point72 Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Point72 Asset Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-15,000
Closed -$1.69M – 778
2015
Q4 		$1.69M Buy
+15,000
New +$1.63M 0.01% 569

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Point72 Asset Management's IBB Position: Q1 2016 in Review

Point72 Asset Management sold out of iShares Biotechnology ETF (IBB) in Q1 2016, closing a stake of 15,000 shares — an estimated $1.69M sold.

Point72 Asset Management first reported a position in IBB in Q4 2015 and held it in 1 quarter. The position peaked at $1.69M in Q4 2015. 414 funds tracked by Wall St. Rank hold IBB as of Q1 2016.

  • Point72 Asset Management reported no remaining iShares Biotechnology ETF position as of Q1 2016 after selling out during the quarter.
  • Point72 Asset Management sold 15,000 iShares Biotechnology ETF shares in Q1 2016, an estimated $1.69M.
  • Point72 Asset Management first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 1 quarter.
  • Point72 Asset Management's iShares Biotechnology ETF position peaked at $1.69M in Q4 2015.
  • 414 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2016.

Based on Point72 Asset Management's 13F filing for Q1 2016, filed 16 May 2016.